C

    CorMedix Inc (CRMD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.26
    -0.04 (-0.48%)

    Market Cap: $646.94M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +7.67%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.10
    Range$-0.17 - $-0.05
    5 analysts
    EPS Revisions
    3
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-0.05+56.1%
    60d ago$-0.09+9.6%
    30d ago$-0.09+9.6%
    7d ago$-0.09+9.6%
    Current$-0.10
    Revenue Consensus
    $53M
    Range$51M - $58M
    5 analysts
    Dec 31, 2026
    EPS Consensus$0.02
    Range$-0.10 - $0.13
    5 analysts
    Revenue Consensus
    $83M
    Range$81M - $90M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.02---
    Sep 26EST
    		-$-0.10---
    Jun 26
    		$0.29$0.26+11.54%Beat+3.6%
    Mar 26
    		$0.35$0.33+6.06%Beat+16.7%
    Dec 25
    		$0.16N/A-78.24%Miss-27.2%
    Sep 25
    		$1.41$0.63+123.81%Beat+2920.0%
    Jun 25
    		$0.28$0.20+40.00%Beat+212.0%
    Mar 25
    		$0.30$0.25+20.00%Beat+220.0%
    Dec 24
    		$0.22$0.14+57.14%Beat+184.6%
    Sep 24
    		$-0.05$-0.10+50.00%Beat+70.6%
    Jun 24
    		$-0.25$-0.25+0.00%Beat+0.0%
    Mar 24
    		$-0.25$-0.28+10.71%Beat-4.2%
    Dec 23
    		$-0.26$-0.20-30.00%Miss-30.0%
    Sep 23
    		$-0.17$-0.21+19.05%Beat+0.0%
    Jun 23
    		$-0.25$-0.24-4.17%Miss-31.6%
    Mar 23
    		$-0.24$-0.20-20.00%Miss-33.3%
    Dec 22
    		$-0.20$-0.19-5.26%Miss+0.0%
    Sep 22
    		$-0.17$-0.23+26.09%Beat+22.7%
    Jun 22
    		$-0.19$-0.21+9.52%Beat-58.3%
    Mar 22
    		$-0.18$-0.22+18.18%Beat+10.0%
    Dec 21
    		$-0.20$-0.23+13.04%Beat-5.3%
    Sep 21
    		$-0.22$-0.18-22.22%Miss+0.0%
    Jun 21
    		$-0.12$-0.19+36.84%Beat+14.3%
    Mar 21
    		$-0.20$-0.18-11.11%Miss+4.8%
    Dec 20
    		$-0.19$-0.22+13.64%Beat+9.5%
    Sep 20
    		$-0.22$-0.25+12.00%Beat+0.0%
    Jun 20
    		$-0.14$-0.24+41.67%Beat+41.7%
    Mar 20
    		$-0.21$-0.23+8.70%Beat+4.5%
    Dec 19
    		$-0.21$-0.24+12.50%Beat-310.0%
    Sep 19
    		$-0.22$-0.25+12.00%Beat+60.0%
    Jun 19
    		$-0.24$-0.21-14.29%Miss+52.0%
    Mar 19
    		$-0.22$-0.28+21.43%Beat+68.6%
    Dec 18
    		$0.10N/A+125.00%Beat+113.0%
    Sep 18
    		$-0.55$-0.30-83.33%Miss+16.7%
    Jun 18
    		$-0.50$-0.50+0.00%Beat+25.4%
    Mar 18
    		$-0.70$-0.50-40.00%Miss+26.3%
    Dec 17
    		$-0.77$-0.60-28.33%Miss+3.8%
    Sep 17
    		$-0.66$-0.65-1.54%Miss+42.6%
    Jun 17
    		$-0.67$-0.80+16.25%Beat-
    Mar 17
    		$-0.95$-0.72-31.94%Miss-
    Dec 16
    		$-0.80$-1.07+25.23%Beat-
    Sep 16
    		$-1.15$-0.75-53.33%Miss-

    Key Metrics

    Valuation
    P/E Ratio3.74EV/EBITDA2.10x
    Price/FCF2.59xFCF Yield38.65%
    Profitability
    Profit Margin40.50%Operating Margin42.10%
    ROE54.90%ROIC30.34%
    Financial Health
    Debt/Equity0.31xInterest Coverage13.36x
    Current Ratio2.56xQuick Ratio2.36x
    Trading Statistics
    Beta1.50Avg Volume1.40M
    52-Week High$14.8652-Week Low$6.12

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.32
    SMA 20$7.92
    SMA 50$8.05
    SMA 200$8.30
    EMA 10$8.22
    EMA 20$8.08
    EMA 50$8.02
    EMA 200$8.50

    MACD

    Line: 0.13Signal: 0.07Hist: 0.06

    ADX

    ADX: 30.7+DI: 24.3-DI: 16.4

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down48.0
    PSAR$7.50

    Bollinger Bands

    Upper Band$8.84
    Lower Band$7.00
    %B Position2333%(Upper)
    Band Width0.68

    RSI (14-Day)

    Neutral
    54.1

    Momentum Oscillators

    Stoch %K63.3
    Stoch %D66.4
    Williams %R-38.3
    ROC (10d)7.7%
    Momentum0.59
    CCI (20d)43.0
    MFI (14d)59.2

    Volatility Measures

    ATR (14d)$0.37(4.5%)
    StdDev (20d)0.46
    Hist Vol70.9%(High)

    Volume Flow

    VWAP$8.20
    OBV-33.1M
    AD Line-74.7M
    CMF (20d)-0.211

    Volume Metrics

    Avg Vol (20d)1.4M
    Vol Ratio0.7x
    VWMA (20d)$7.95

    Pivot Points

    R3$8.61
    R2$8.50
    R1$8.40
    Pivot Point$8.29
    S1$8.19
    S2$8.08
    S3$7.98

    Advanced Oscillators

    TSI8.30
    Ultimate Osc45.2
    KST45.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$101.93M$127.43M$118.37M$100.65M$39.74M$39.08M$31.21M$11.46M$806,119$0$304,110$0
    Cost of Revenue$24.80M$22.30M$11.06M$7.57M$1.86M$1.60M$1.07M$634,650$509,839$818,539$53,507$0
    Gross Profit$77.13M$105.12M$107.31M$93.08M$37.87M$37.48M$30.03M$10.77M$296,280$-818,539$-53,507$0
    Operating Expenses$34.22M$41.46M$48.18M$41.73M$18.33M$17.36M$17.10M$14.06M$15.60M$15.89M$15.67M$10.47M
    R&D$6.68M$7.21M$8.60M$5.10M$2.44M$3.19M$1.73M$727,119$650,988$837,445$2.29M$2.66M
    SG&A$15.09M$21.72M$23.57M$25.45M$9.50M$9.69M$7.11M$6.58M$7.56M$8.71M$2.58M$3.74M
    Operating Income$42.91M$63.66M$59.13M$51.35M$19.54M$20.13M$12.94M$-3,287,336$-15,300,826$-16,704,236$-15,668,744$-10,467,283
    Interest Income$2.55M$0$889,982$1.56M$0$0$510,592$553,856$657,366$857,186$920,043$765,241
    Interest Expense$4.18M$8.01M$1.82M$948,242$0$0$9,602$10,007$6,556$9,835$6,556$13,113
    Income Before Tax$38.73M$55.65M$56.45M$52.58M$20.35M$20.64M$13.46M$-2,776,812$-14,151,489$-15,860,893$-14,754,029$-9,744,354
    Income Tax Expense$12.74M$17.04M$42.43M$-55,986,802$522,000$0$-230$0$0$-1,394,770$0$0
    Net Income$25.99M$38.60M$14.02M$108.56M$19.83M$20.64M$13.46M$-2,776,812$-14,151,489$-14,466,123$-14,754,029$-9,744,354
    EBITDA$46.73M$66.19M$67.26M$55.68M$20.51M$20.81M$13.14M$-3,205,947$-14,688,961$-16,650,774$-15,614,009$-10,444,620
    EBIT$36.19M$55.65M$55.99M$51.96M$20.35M$20.64M$12.96M$-3,320,661$-14,802,299$-16,708,244$-15,667,516$-10,496,482
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CRMD

    News

    CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    CorMedix (CRMD) is expected to report increased earnings and significantly higher revenues for the quarter ended March 2026, with an earnings release anticipated on May 14. Despite the positive growth outlook, a recent downward revision in the consensus EPS estimate and a negative Earnings ESP make it difficult to conclusively predict an earnings beat. Investors are advised to consider other factors beyond just earnings predictions.

    Eastern Progress•8/19/26•
    Somewhat-Bearish

    Research Analysts Set Expectations for CorMedix Q3 Earnings

    HC Wainwright has revised its Q3 2026 EPS estimate for CorMedix (NASDAQ:CRMD) to a loss of $0.05 per share, an improvement from its previous forecast. Analyst sentiment for CorMedix remains largely positive, with a "Moderate Buy" consensus and an average price target of $15. The company recently reported Q3 earnings of $0.29 per share and revenue of $101.93 million, both exceeding consensus estimates.

    MarketBeat•8/18/26•
    Bullish

    CorMedix (NASDAQ:CRMD) Shares Up 7.3% on Analyst Upgrade

    CorMedix (NASDAQ:CRMD) shares increased by 7.3% following Royal Bank of Canada's upgrade of its price target from $13 to $14, maintaining an "outperform" rating. The company also surpassed its Q2 earnings and revenue estimates, reporting $0.29 EPS against a $0.24 estimate and $101.93 million in revenue compared to a $96.04 million forecast. Analyst sentiment for CRMD remains positive, with a consensus "Moderate Buy" rating and an average price target of $15.

    MarketBeat•8/17/26•
    Bullish

    FY2026 EPS Estimates for CorMedix Raised by HC Wainwright

    HC Wainwright has increased its FY2026 EPS estimate for CorMedix to $0.54 from $0.51, matching the current analyst consensus. The company recently surpassed quarterly expectations, reporting $0.29 EPS and $101.93 million in revenue. Analyst sentiment remains largely positive, with a "Moderate Buy" consensus and an average price target of $15.00 for CorMedix (NASDAQ:CRMD).

    MarketBeat•8/17/26•
    Bullish

    (CRMD) as a Liquidity Pulse for Institutional Tactics

    Cormedix Inc. (NASDAQ: CRMD) shows a mid-channel oscillation pattern with mixed sentiment across different time horizons. An exceptional short setup is identified with a significant risk-reward ratio. The article details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis to guide institutional tactics.

    Stock Traders Daily•8/16/26•
    Somewhat-Bearish

    Frequently Asked Questions About CRMD

    Does CRMD pay dividends?
    CorMedix Inc (CRMD) does not currently pay a regular dividend.
    What is CRMD's P/E ratio?
    CorMedix Inc has a price-to-earnings (P/E) ratio of 3.74.
    What is CRMD's market cap?
    CorMedix Inc (CRMD) has a market capitalization of $646.94M with a current stock price of $8.26.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In